CGE Partners announces investment in Datapharm

CGE Partners invests in Datapharm, a leading provider of regulatory-driven medicines information and software solutions to the pharmaceutical industry.

LONDON, 28th February 2022

CGE Partners (“CGE”) is pleased to announce its investment in Datapharm, a leading provider of regulatory-driven medicines information and software solutions to the pharmaceutical industry. Datapharm’s core platform, the electronic medicines compendium (“emc”), is the UK’s leading source of trusted medicines information used by pharmaceutical companies, healthcare professionals, and patients.

Datapharm lies at the core of the UK medicines information ecosystem, benefitting from 45 years of industry expertise and longstanding trusted relationships with customers. The business supports pharmaceutical companies in maintaining regulatory compliance and its software solutions are trusted by over 300 of the world’s top global life sciences companies. CGE is partnering with Datapharm’s management team to accelerate new product development, international expansion, and strategic acquisitions.

Simon Abrams, CEO of Datapharm, commented: “We are excited to welcome CGE as our investment partner to achieve our vision of improving the accessibility and excellence of medicines information in the pharmaceutical industry. With CGE’s support, Datapharm will continue to expand its suite of best-in-class software solutions to our customers whilst maintaining its reputation for independence and trust.”

CGE Partners commented: “We are delighted to be partnering with Simon and the management team at Datapharm. Datapharm’s mission-critical solutions and commitment to patient safety and regulatory compliance strongly align with our focus on partnering with purposeful businesses that deliver a positive impact.”

Datapharm marks the sixth investment from CGE’s first fund.


About Datapharm –

Datapharm is a medicines information company that provides technology-enabled solutions to the global life sciences and wider healthcare sectors. Its regulatory, compliance and commercial software solutions facilitate the accessibility and usability of medicines information to healthcare professionals and patients.


About CGE Partners –

CGE Partners is a €440m European mid-market investment fund. CGE invests in businesses using technology to facilitate the transition to a more digital, renewable, secure and compliant future, providing capital and expertise to accelerate expansion in global markets. CGE is proud to be a certified B Corp, highlighting its commitment to meeting exceptional standards of corporate governance, transparency, accountability, and social and environmental responsibility.

Media enquiries

CGE – Sara Davy / Stephen Moore –  /